Unicycive Therapeutics, Inc.
UNCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $53,186 | $21,300 | $8,131 | $24,052 |
| - Cash | $26,142 | $9,701 | $455 | $16,579 |
| + Debt | $773 | $811 | $201 | $335 |
| Enterprise Value | $27,817 | $12,410 | $7,877 | $7,808 |
| Revenue | $0 | $675 | $951 | $0 |
| % Growth | -100% | -29% | – | – |
| Gross Profit | $0 | $675 | $951 | $0 |
| % Margin | – | 100% | 100% | – |
| EBITDA | -$36,230 | -$30,178 | -$17,891 | -$9,376 |
| % Margin | – | -4,470.8% | -1,881.3% | – |
| Net Income | -$36,729 | -$30,544 | -$18,058 | -$10,017 |
| % Margin | – | -4,525% | -1,898.8% | – |
| EPS Diluted | -5.6 | -1.28 | -1.2 | -8.6 |
| % Growth | -337.5% | -6.7% | 86% | – |
| Operating Cash Flow | -$28,575 | -$18,283 | -$15,651 | -$5,767 |
| Capital Expenditures | -$72 | -$12 | -$2 | -$29 |
| Free Cash Flow | -$28,647 | -$18,295 | -$15,653 | -$5,796 |